Curative Ventures V LLC
holder of greater than 5% of our common stock; affiliate of Bronson Crouch, our Chief Executive Officer and Chairman
Amount not stated
Investors' rights, voting and right of first refusal agreement entered in connection with purchase of convertible preferred stock prior to IPO (registration rights, information rights and rights of first offer)
With Curative Ventures V LLC
Open in proxy
